Kevin Kim

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Advisory Board
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    Advisory Board
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eisai
    Topic:
    Advisory Board
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Regeneron
    Topic:
    Advisory Board
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    Advisory Board
    Date added:
    01/09/2025
    Date updated:
    01/09/2025

Pages

Return to Northern California Hematology Oncology Conference: A Tumor Board Case-Based Approach to the Latest Breakthroughs